ARA 290

ARA-290, also known as Cibinetide, is a synthetic peptide derived from erythropoietin (EPO), specifically engineered to retain tissue-protective and anti-inflammatory properties without affecting red blood cell production. This selective mechanism makes ARA-290 a promising compound in research focused on nerve repair, inflammation control, and cellular protection.

ARA-290 works by targeting the innate repair receptor (IRR), also known as the EPOR/CD131 receptor complex, which is involved in tissue protection and regeneration. By activating this pathway, ARA-290 may help reduce inflammation, support nerve regeneration, and enhance cellular recovery following injury or stress.

Key Features:

• Selective EPO-derived peptide without hematopoietic effects

• Targets tissue-protective pathways (EPOR/CD131 receptor)

• Supports anti-inflammatory and regenerative processes

• Promotes nerve health and cellular repair

Potential Applications:
ARA-290 is commonly studied in research related to neuropathic pain, small fiber neuropathy, inflammatory conditions, and tissue damage. It is also of interest in fields exploring neuroprotection and immune system modulation.

Usage:
Intended for use in controlled research or clinical environments. Dosage and administration protocols may vary depending on study design and professional guidance.

Important Information:
This product is intended for research use only and is not approved for general human use in many regions. Clinical studies are ongoing to evaluate its safety and effectiveness.